Latest CYCN reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
Cyclerion Therapeutics logo
Cyclerion Therapeutics CYCN
$ 3.0 4.6%

Cyclerion Therapeutics EBITDA per Share 2011-2024 | CYCN

Annual EBITDA per Share Cyclerion Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- -8.5 -1.4 -2.46 -4.47 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.4 -8.5 -4.21

Quarterly EBITDA per Share Cyclerion Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - -2.05 -6.15 -0.3 - -0.25 -0.44 -0.39 - -0.66 -0.69 -0.72 - -1 -1.18 -1.35 K - -1.06 K -1.07 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.25 -1.35 K -249